Trademark: 79336602
Word
IMMULAB
Status Date
Tuesday, January 10, 2023
Registration Number
6945376
Registration Date
Tuesday, January 10, 2023
Filing Date
Monday, October 4, 2021
Published for Opposition
Tuesday, October 25, 2022
5 Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, namely, platelets, plasma and red blood cells; pharmaceutical test kits in this class, being for diagnostic medical purposes, namely, diagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposes, namely, blood plasma, reagent blood cells; reagents for medical use, namely, reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparations, namely, reagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparations, namely, reagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use
1 Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes, all the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screening, blood grouping, and the typing and detection of specific blood cells for scientific and research purposes
The mark consists of of the wording IMMULAB, with two dots over the letter I in blue, with LAB in blue, and with IMMU in gray. To the right is a black, gray, and blue butterfly.
The color(s) gray, black and blue is/are claimed as a feature of the mark.
May 17, 2023
Final Decision Transaction Processed By Ib
Apr 26, 2023
Final Disposition Notice Sent To Ib
Apr 26, 2023
Final Disposition Processed
Apr 10, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 10, 2023
Notice Of Registration Confirmation Emailed
Jan 10, 2023
Registered-Principal Register
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 19, 2022
Approved For Pub - Principal Register
Aug 26, 2022
Teas/Email Correspondence Entered
Aug 25, 2022
Correspondence Received In Law Office
Aug 25, 2022
Teas Response To Office Action Received
Aug 23, 2022
Refusal Processed By Ib
Jul 29, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 29, 2022
Refusal Processed By Mpu
Jul 8, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 7, 2022
Non-Final Action Written
Jul 7, 2022
Assigned To Examiner
Mar 29, 2022
Application Filing Receipt Mailed
Mar 25, 2022
New Application Office Supplied Data Entered
Mar 24, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
